Wiley and Abridge have announced a partnership to integrate Cochrane's clinical evidence into the Abridge Assistant, an AI-powered clinical decision support platform used across more than 300 United States health systems.
Under the agreement, Wiley will license the Cochrane Database of Systematic Reviews and Cochrane Clinical Answers to Abridge. The Cochrane Database of Systematic Reviews contains systematic reviews used to inform clinical guidelines worldwide, while Cochrane Clinical Answers provides curated clinical insights derived from these reviews. The licensed content will be incorporated into responses generated by the Abridge Assistant as concise summaries with citations. Full-text access will remain available to Wiley subscribers.
The integration is intended to help clinicians access relevant medical evidence when making patient-care decisions. Healthcare professionals often need to assess complex patient circumstances, review medical information, and determine how published evidence applies to individual cases. The Abridge Assistant provides context-aware clinical decision support by drawing on patient medical records, clinical conversations, and trusted medical literature to generate cited responses relevant to each patient's circumstances.
As part of the agreement, Wiley will license nearly 10,000 systematic reviews and approximately 4,000 clinical answers from Cochrane's collection to Abridge. The content will supplement the other published evidence sources already available through the Abridge Assistant during clinical encounters. Abridge is used across more than 300 U.S. health systems and is expected to support more than 120 million patient encounters in 2026.
The multi-year agreement covers the integration of Cochrane evidence into the Abridge Assistant's clinical decision support capabilities for healthcare organizations in the United States. The companies also plan to explore further opportunities to incorporate evidence-based content into clinical workflows.
Click here to read the original press release.